RxDoctor Payments Data

Krista Jones, APRN

Family · Monroe, LANPI 1326470485

Payments from drug & device makers

$1,650in general payments, 2019–2025

Across 84 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$361
  • Novartis$204
  • E.r. Squibb & Sons, L.L.C.$146
  • Esperion Therapeutics, Inc.$120
  • Lexicon Pharmaceuticals, Inc.$96
  • Amgen$93
  • plus $630 from 18 others

What the payments were for

  • Food & beverage$1,650100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,650 in reported general payments places this provider in the 70th percentile of 3,610 family providers in Louisiana.

See all family providers in Louisiana

Medicare billing

Part B allowed, 2024
$87,301
Medicare patients
548
Services billed
2,015

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban97$84,163
EntrestoSacubitril/Valsartan28$27,083
JardianceEmpagliflozin11$11,442
FarxigaDapagliflozin Propanediol11$6,244
LivaloPitavastatin Calcium11$5,346
Metoprolol Succinate228$2,615
Propafenone Hcl ErPropafenone Hcl15$1,769
Valsartan87$1,699
Nifedipine ErNifedipine77$1,303
Diltiazem 24hr Er (Cd)Diltiazem Hcl45$1,240
Propafenone Hcl27$1,188
Atorvastatin Calcium90$1,135
Nebivolol Hcl18$1,021
Rosuvastatin Calcium77$909
Flecainide Acetate13$802

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$84,16397 claims
NovartisEntresto$204$27,08328 claims
Boehringer IngelheimJardiance$48$11,44211 claims
AstraZenecaFarxiga$46$6,24411 claims
Kowa Pharmaceuticals America, Inc.Livalo$40$5,34611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 3,610 family providers in Louisiana.

Other family in Monroe

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →